المؤلفون: Oaknin, Ana, Friedman, Claire F, Roman, Lynda D, D’Souza, Anishka, Brana, Irene, Bidard, François-Clement, Goldman, Jonathan, Alvarez, Edwin A, Boni, Valentina, ElNaggar, Adam C, Passalacqua, Rodolfo, T.M., Khanh, Santin, Alessandro D, Keyvanjah, Kiana, Xu, Feng, Eli, Lisa D, Lalani, Alshad S, Bryce, Richard P, Hyman, David M, Meric-Bernstam, Funda, Solit, David B, Monk, Bradley J

المصدر: Gynecologic Oncology. 159(1)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Cancer, Clinical Research, Clinical Trials and Supportive Activities, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, 6.2 Cellular and gene therapies, Administration, Oral, Adult, Diarrhea, Female, Humans, Kaplan-Meier Estimate, Middle Aged, Mutation, Nausea, Neoplasm Recurrence, Local, Progression-Free Survival, Protein Kinase Inhibitors, Quinolines, Receptor, ErbB-2, Response Evaluation Criteria in Solid Tumors, Severity of Illness Index, Uterine Cervical Neoplasms, Cervical cancer, HER2 mutant, Neratinib, Clinical trial, Tyrosine kinase inhibitor, Receptor, erbB-2, Paediatrics and Reproductive Medicine, Oncology & Carcinogenesis, Clinical sciences, Oncology and carcinogenesis, Reproductive medicine

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/83m8v37nTest

المؤلفون: Oaknin, Ana, Friedman, Claire F, Roman, Lynda D, D'Souza, Anishka, Brana, Irene, Bidard, François-Clement, Goldman, Jonathan, Alvarez, Edwin A, Boni, Valentina, ElNaggar, Adam C, Passalacqua, Rodolfo, Do, Khanh TM, Santin, Alessandro D, Keyvanjah, Kiana, Xu, Feng, Eli, Lisa D, Lalani, Alshad S, Bryce, Richard P, Hyman, David M, Meric-Bernstam, Funda, Solit, David B, Monk, Bradley J

المصدر: Gynecologic oncology. 159(1)

مصطلحات موضوعية: Humans, Neoplasm Recurrence, Local, Diarrhea, Nausea, Quinolines, Receptor, erbB-2, Protein Kinase Inhibitors, Administration, Oral, Severity of Illness Index, Mutation, Adult, Middle Aged, Uterine Cervical Neoplasms, Female, Kaplan-Meier Estimate, Response Evaluation Criteria in Solid Tumors, Progression-Free Survival, Cervical cancer, Clinical trial, HER2 mutant, Neratinib, Tyrosine kinase inhibitor, Receptor, ErbB-2, Clinical Trials and Supportive Activities, Cancer, Clinical Research, 6.1 Pharmaceuticals, 6.2 Cellular and gene therapies, Oncology & Carcinogenesis, Oncology and Carcinogenesis, Paediatrics and Reproductive Medicine

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/83m8v37nTest